// App-Quantinova.ai

e20527 : Effect of brain metastases on survival and systemic treatment of EGFR/ALK-driven non-small cell lung cancer (NSCLC).

Researchers

Presenter

  • Mark Doherty

Principal Investigators

  • Grzegorz Korpanty

  • Pascale Tomasini

  • Moein Alizadeh

  • Kevin Jao

  • Catherine Labbe

  • Celine Mascaux

  • Petra Martin

  • Suzanne Kamel-Reid

  • Melania Pintilie

  • Geoffrey Liu

  • Penelope Ann Bradbury

  • Ronald Feld

  • Natasha B. Leighl

  • Caroline Chung

  • Frances A. Shepherd

Medical Centers

  • Princess Margaret Cancer Center, Toronto, ON, Canada

  • Princess Margaret Hospital, Toronto, ON, Canada

  • Princess Margaret Cancer Centre University Health Network, Toronto, Ontario, Canada

  • Centre Integre de Cancerologie de Laval, Laval, QC, Canada

  • Department of Pathology and Laboratory Medicine, University Health Network, Toronto, ON, Canada

  • Princess Margaret Hospital, University Health Network, University of Toronto, Toronto, ON, Canada

  • Ontario Cancer Institute, Princess Margaret Hospital, Toronto, ON, Canada

  • Princess Margaret Cancer Centre, University Health Network, Division of Medical Oncology and Hematology, Toronto, ON, Canada

  • Princess Margaret Cancer Centre University Health Network, Toronto, Ontario, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Non Small Cell Lung cancer

  • Brain metastasis

  • Lung Cancer

  • Solid malignancies

Biomarkers

  • Epidermal growth factor receptor

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved